Human Sodium-coupled neutral amino acid transporter 1 (SLC38A1) ELISA Kit

Category: Assay Kits
Catalog
AE18630HU
(Ships in 5-10 business days)

Questions? Contact us

Call (800) 832-2611

arp-guarantee
- +
$0.00
More Information
Product Name Human Sodium-coupled neutral amino acid transporter 1 (SLC38A1) ELISA Kit
Description Amino acid transporters play essential roles in the uptake of nutrients, production of energy, chemical metabolism, detoxification, and neurotransmitter cycling. SLC38A1 is an important transporter of glutamine, an intermediate in the detoxification of ammonia and the production of urea. Glutamine serves as a precursor for the synaptic transmitter, glutamate.The deduced 487-amino acid protein is predicted to have a cytoplasmic N terminus followed by 11 putative transmembrane domains and an extracellular C terminus. ATA1 has 2 N-glycosylation sites in the putative extracellular loop between transmembrane domains 5 and 6, and several protein kinase C phosphorylation sites. ATA1 shares 93% identity with rat Ata1 and 52% identity with human ATA2 (SLC38A2). This assay has high sensitivity and excellent specificity for detection of Human SLC38A1. No significant cross-reactivity or interference between Human SLC38A1 and analogues was observed.
Synonyms ATA1, NAT2, SAT1, SNAT1, amino acid transporter system A1
Method Sandwich ELISA
Detection Range 0.156-10 ng/mL
Sensitivity 0.055 ng/mL
Reactivity Human
Sample Types Serum, Plasma, Other biological fluids.
Background Amino acid transporters play essential roles in the uptake of nutrients, production of energy, chemical metabolism, detoxification, and neurotransmitter cycling. SLC38A1 is an important transporter of glutamine, an intermediate in the detoxification of ammonia and the production of urea. Glutamine serves as a precursor for the synaptic transmitter, glutamate.The deduced 487-amino acid protein is predicted to have a cytoplasmic N terminus followed by 11 putative transmembrane domains and an extracellular C terminus. ATA1 has 2 N-glycosylation sites in the putative extracellular loop between transmembrane domains 5 and 6, and several protein kinase C phosphorylation sites. ATA1 shares 93% identity with rat Ata1 and 52% identity with human ATA2 (SLC38A2).
Supplier Abebio

All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.